South Korea
· Delayed Price · Currency is KRW Aptamer Sciences Statistics
Total Valuation
Aptamer Sciences has a market cap or net worth of KRW 31.75 billion. The enterprise value is 19.33 billion.
| Market Cap | 31.75B |
| Enterprise Value | 19.33B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Aptamer Sciences has 16.98 million shares outstanding. The number of shares has decreased by -11.12% in one year.
| Shares Outstanding | 16.98M |
| Shares Change (YoY) | -11.12% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 28.82% |
| Owned by Institutions (%) | n/a |
| Float | 12.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 146.99 |
| PB Ratio | 2.53 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.43 |
| EV / Sales | 89.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.81 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 66.96.
| Current Ratio | 1.49 |
| Quick Ratio | 1.41 |
| Debt / Equity | 66.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.82 |
| Interest Coverage | -8.15 |
Financial Efficiency
Return on equity (ROE) is -68.27% and return on invested capital (ROIC) is -26.84%.
| Return on Equity (ROE) | -68.27% |
| Return on Assets (ROA) | -20.38% |
| Return on Capital (ROIC) | -26.84% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -52.33% |
| 50-Day Moving Average | 2,848.52 |
| 200-Day Moving Average | 3,054.48 |
| Relative Strength Index (RSI) | 34.42 |
| Average Volume (20 Days) | 1,374,106 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aptamer Sciences had revenue of KRW 216.07 million and -13.48 billion in losses. Loss per share was -793.57.
| Revenue | 216.07M |
| Gross Profit | 170.20M |
| Operating Income | -11.91B |
| Pretax Income | -13.48B |
| Net Income | -13.48B |
| EBITDA | -11.36B |
| EBIT | -11.91B |
| Loss Per Share | -793.57 |
Balance Sheet
The company has 21.58 billion in cash and 8.70 billion in debt, giving a net cash position of 12.88 billion or 758.70 per share.
| Cash & Cash Equivalents | 21.58B |
| Total Debt | 8.70B |
| Net Cash | 12.88B |
| Net Cash Per Share | 758.70 |
| Equity (Book Value) | 12.99B |
| Book Value Per Share | 738.10 |
| Working Capital | 7.64B |
Cash Flow
In the last 12 months, operating cash flow was -10.41 billion and capital expenditures -237.24 million, giving a free cash flow of -10.65 billion.
| Operating Cash Flow | -10.41B |
| Capital Expenditures | -237.24M |
| Free Cash Flow | -10.65B |
| FCF Per Share | -627.29 |
Margins
| Gross Margin | 78.77% |
| Operating Margin | -5,513.26% |
| Pretax Margin | -6,237.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -4,929.82% |
Dividends & Yields
Aptamer Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.12% |
| Shareholder Yield | 11.12% |
| Earnings Yield | -42.44% |
| FCF Yield | -33.55% |
Stock Splits
The last stock split was on February 28, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Feb 28, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |